DASH vs PFE · P/E 76, rev $13.72B vs P/E 20, rev $62.58B
DoorDash, Inc. Class A Common Stock (DASH) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the DASH and PFE stock pages for the full models.
Not investment advice.